Question.2631 - The purpose of this assignment is to have students research the measurement tools of NP performance. Through the use of quality patient outcomes, students will list and discuss three different patient interventions and how they would specifically measure the outcomes, and how these primary care interventions result in improved patient outcomes and cost savings for the practice. In addition, students will discuss how these interventions result in improved patient ratings.A c t i v i t y L e a r n i n g O u t c o m e s Through this assignment, the student will demonstrate the ability to: 1. Employ strategies to impact the development, implementation, and consequences of holistic healthcare policies using evidence-based practice principles (CO1) 2. Critically analyze how healthcare systems and APRN practice are organized and influenced by ethical, legal, economic, and political factors (CO2) 3. Demonstrate professional and personal growth concerning the advocacy role of advanced practice nursing in fostering policy within diverse healthcare settings (CO3) 4. Analyze social, historical, ethical, and political contexts of healthcare policies and advanced practice leadership (CO4)5. Advocate for institutional, local, national, and international policies that fosters person- centered healthcare and nursing practice (CO5)??25/07/2023, 10:06 Week 3: Quality Healthcare: Measuring NP Performancehttps://chamberlain.instructure.com/courses/126559/assignments/4066316 2/8 D u e D a t e : S u n d a y o f w e e k 3 b y 11 : 5 9 P M M S T Students are expected to submit assignments by the time they are due. Assignments submitted after the due date and time will receive a deduction of 10% of the total points possible for that assignment for each day the assignment is late. Assignments will be accepted, with a penalty as described, up to a maximum of three days late, after which point a zero will be recorded for the assignment. Quizzes and discussions are not considered assignments and are not part of the late assignment policy.To t a l P o i n t s P o s s i b l e This assignment is worth 200 points.P r e p a r i n g t h e A s s i g n m e n t The National Committee for Quality Assurance (NCQA) was formed to ensure the quality of patient care and measurement of patient outcomes with set standards. Healthcare Effectiveness Data and Information Set (HEDIS) is a performance measurement tool used by millions of health insurance plans. There are 6 domains of care: Effectiveness of Care Access/Availability of Care Experience of Care Utilization and Risk Adjusted Utilization Health Plan Descriptive Information Measures Collected Using Electronic Clinical Data Systems You may access the 6 domains of care by clicking this link: (NCQA, n.d. https://www.ncqa.org/hedis/ (https://www.ncqa.org/hedis/) ) As an APN, productivity will be an important measurement for the practice to determine reimbursement and salary. Fee-for-service practices will require a set number of patients per day to maintain productivity. A capitated practice will require the APN to have a large panel of patients but also will focus on controlling costs. This can be accomplished through effective primary care that is accessible, convenient for the patients, and has a method of measuring the quality of care. Write a formal paper in APA format with a title page, introduction, the three required elements below, conclusion, and reference page. You are now employed as an NP in primary care. Choose one performance measure from one of the six domains of care, i.e. Adult BMI Assessment, Prenatal, and Postpartum care, etc.25/07/2023, 10:06 Week 3: Quality Healthcare: Measuring NP Performancehttps://chamberlain.instructure.com/courses/126559/assignments/4066316 3/8 Develop three different patient interventions for that one performance measure and how you would specifically implement the intervention and measure the outcomes for that particular performance measure in clinical practice. How would these primary care interventions result in improved patient outcomes and healthcare cost savings? How can these interventions result in improved NP patient ratings? Category Points % DescriptionList and discuss three different patient interventions and how you would specifically measure the outcomes.60 30%From the National Committee for Quality Assurance (NCQA) website discuss three patient interventions for the one performance measure. Develop a measurement tool to track patient outcomes.How would these primary care interventions result in improved patient outcomes and cost savings for the practice?60 30%Discuss how the interventions can result in improved patient outcomes and cost savings for the practice.How can these interventions result in improved patient ratings?60 30%Discuss how these interventions can result in improved patient ratings (an NP’s patient scorecard).180 90%Total CONTENT Points = 180 ptsClarity of Writing10 5%Excellent use of standard English showing original thought. No spelling or grammar errors. Well organized with proper flow of meaning.25/07/2023, 10:06 Week 3: Quality Healthcare: Measuring NP Performancehttps://chamberlain.instructure.com/courses/126559/assignments/4066316 4/8 NR506NP WK3 Quality Healthcare Paper_SEPT19 Category Points % Description APA Format10 5%APA format, grammar, spelling, and/or punctuation are accurate.20 10%Total FORMAT Points = 20 pts200 100%ASSIGNMENT TOTAL= 200 points
Answer Below:
Breast xxxxxx Screening xxxxxxxxx is xxx process xx examining x woman x breasts xxx cancer xxxxxx the xxxxx of xxx symptoms xxxxxxxxxxx MRI xxxxxxxxxx thermography xxxxxxxxxxxxx tissue xxxxxx and xxxxxx clinical xxxxxxx exam xxx self-digital xxxx are xxxx few xx the xxxxxxxxxx used xx test xxx breast xxxxxx Women xxxxxx be xxxx to xxxx an xxxxxxxx conversation xxxx their xxxx healthcare xxxxxxxxxxxx and xxxx significant xxxxxxxxxxx into xxx ultimate xxxxxx of xxxxx screening xxxxxxxxx is xxxx for xxxx Informed xxx collaborative xxxxxxxxxxxxxxx describes xxxx process xxxxx females xx North xxxxxxx breast xxxxxx is xxx second xxxxxxx cause xx mortality xxxxxx cancer xxxxxxx in xxxxx and xxxxxx the xxxxx of xx ACOG xxxxxxxxx as xxxxxxxx Practise xxxxxx APNs xx have x responsibility xx adhere xx the xxxxxxxxxx established xx organizations xxxx as xxx U x Preventive xxxxxxxx Task xxxxx USPSTF xxx College xx Obstetricians xxx Gynaecologists xxxx the xxxxxxxx Cancer xxxxxxx ACS xxx National xxxxxx Institute xxx and xxxxx G xxxxx to xxxx a xxx Patient xxxxxxxxxxxxx for xxxxxx cancer xxxxxxxxx Screening xxx breast xxxxxx is x great xxx to xxxxxxxx and xxxxx the xxxxxxx before xxx symptoms xxxxxx To xxx it xxxxxx screenings xxxx lives xx order xx provide xxx best xxxx possible xxx my xxxxxx cancer xxxxxxxxx patients x will xxxxxx that xxx women xxx visit xx clinic xxxxxx to xxx guidelines xxxxxxxxxxx by xxx United xxxxxx Preventive xxxxxxxx Task xxxxx USPTF xxxxxxxx et xx Therefore xxxxx two xxxxx women xxxx - xxxx have x mammography xxxxx to xxxxxxxxxx any xxxxx the xxxxxxxxxxx and xxxxxxxxxx benefits xxx drawbacks xx women xxxxx the xxx of xxxx be xxxxx into xxxxxxx Patients xxx continue xx get xxxxxxx if xxxx are xx years xxx and xxxx it xxxxx benefit xxxxx health xxx if xxxx don x think xxxxxxxxx is xxxxxxxxxx they xxx t xxxx to xxxxxxx it xxxxxxxxx amp xxx There xx not xxxxxx evidence xx suggest xxxxxx disease xxxx screening xx thought xx be xxxxxxx beyond xxx Screening xxx prevent xxxxxx from xxxxxxxxxxx and xx s xxxx useful xxx women xxxxxxx the xxxx of xxx However xx the xxx bracket xx false xxxxxxxx and xxxxx negative xxxxxxxx may xxxxx owing xx factors xxxx the xxxxxxx of xxxxxx issues xxxxxxx to xxxxxxxx testing xxxxx costs xxx patient xxxx money xxxxxxxxxxxxxx and xxxxxxxxx conditions xxx also x result xxxxxx Early xxxxxxxxxx are xxx necessary xxxxx a xxxxxx history xx cancer xx atypical xxxxxx are xxxxxxxx making xxx advantages xx screening xx this xxx totally xxxxxxxxx on xxxxxxx desire xxxxxxxxx those xxxxxxx the xxxx of xxx yields xxxx advantages xxxx those xxxxxxx the xxxx of xxx Miller xxxxxx than xxxxxxx only xx patients xxxxxxx of xxxxxxxxx completion x would xx a xxxxxx check xx verify xxxx all xxxxxxxxx screenings xxx women xxxx to xxx been xxxxxxxxx Interventions xxxxxx Mammogram xxxxxxx When x get x patient x mammography xxxxxx from xxx prior xxxx and xxxxxxx the xxxxxxx s xxxx to xxxxxx the xxxxxx s xxxxxxxx I xxxx compare xxx two xxxx of xxxx Momenimovahed xxx Salehiniya xxx percentage xx patients xxx actually xxxx screening xxxxxxxxxxx is xxxxxxxx to xxxx considerably xx physicians xxxx an xxxxxx role xx the xxxxxxx by xxxxxxxxx mammograms xxxxxxxx patients xxx reaching xxx to xxxxx who xxx unable xx comply xx order xx better xxxxxxxxxx the xxxxxxx they xxxx and xxx to xxxxxx them xxxxxxx with xxxxxxxxx If x patient xxxx not xxxxx grasp xxx need xx getting x mammogram x will xxxx them xxx literature xxxxx with xxx mammography xxxxxxxxxxxx and xxxx them xx ask xxxxxxxxx Through xx intervention x will xxxxxxxx how xxxx people xxxx the xxxxxxxxx test xxxxxx and xxx many xxxxxx took xxx test xxxxx receiving xxx booklet xxxx might xxxx that xxxxxxxx are xxxx open xx being xxxxxx now xxxx they xxxx a xxxxxx understanding xx the xxxxxxx and xxx prepared xxx more xxxxxxxx questioning xxxxxxxxxx et xx They xxxx feel xxxx they xxxx a xxxxx in xxx process xxxxx boosts xxxxx motivation xx follow xxxxxxx with xxx treatment xxxx It x a xxxxxxxxxxxxx method xx caring xxx and xxxxxxxxxxxxx with xxxxxxxx Obtain xxxxxx History xx order xx provide xxx most xxxxxxxxxxx treatment xxx each xxxxxxxxxx patient xx is xxxxxxx to xxxx a xxxxxxxx picture xx their xxxxxx history xxxxxxxx a xxxxxxxxx technique xx treatment xxxxxxxxx may xx pivotal xxx instance xxx a xxxxxxx with xxxxxx cancer xxx has x family xxxxxxx of xxxxxxxxx who xxxx been xxxxxxx are xxxxx treated xx have xxxx from xxx illness x higher xxxxxxxxx of xxxxxx cancer xxxxxxxxxx or xxxxxxx testing xxx be xxxxxxxxx for xxxxxxxx with x family xxxxxxx of xxx disease xxxx Patients xx high xxxx for xxxxxxx breast xxxxxx BRCA xxxx Lynch xxxxxxxx will xx identified xxxx this xxxx Increased xxxxxxxxxx of xxxxx people xxx the xxxxxxxxx to xxxxxxxx breast xxxxxx early xxxxxxxx for xxxx effective xxxxxxxxx and x speedier xxxxxxxx Breast xxxxxx may xx caused xx mutations xx the xxxx or xxxx genes xxxxxxx of xxx gastrointestinal xxxxx and xxxxxxxx can xx caused xx mutations xx the xxxxx syndrome xxxx and xx on xxxxxxxx et xx Survival xxxxx may xx increased xxxx early xxxxxxxxx and xxxxxxx therapy xxxxxx to xxxxxxx testing xxx regular xxxxxxxxxx The xxxxxxxx percentage xxx be xxxxxxx increased xxxx early xxxxxxxxx Conclusion xx were xxxx to xxxx individuals xxxx aberrant xxxxxxx by xxxxxxxxx them xxx breast xxxxxx according xx USPTF xxxxxxxxx guidelines xxxxxxxx with xxxxxxx anomalies xxx those xxxx a xxxxxx history xx the xxxxxxxx undergo xxxxxxx testing xx an xxxxxx to xxxxxxxx the xxxxxxxxxx genetic xxxxx Regular xxxxxx allow xxx prompt xxxxxxxxx and x higher xxxxxx of xxxxxxxx by xxxxxxxxxxxx rapid xxxxxxx crossover xx reviewing xxx results xx person xx can xx sure xxxx our xxxxxxxx are xxxxxxxx following xxx recommendations xxx scheduling xxxxxxxxxx by xxxxxxxxxxxx booklets xxx engaging xxxxxxxx further xx conversations xxxxx screening xxxxx and xx collecting x thorough xxxxxx history xxxx will xxxx direct xxxxxx care xxxxxxxxx participation xxxxx may xx raised xxx breast xxxxxx mortality xxxxx lowered xxxxxxx researching xxx developing xxxxxxxxx therapies xxxx are xxxxxxxxxx to xxxx patient x requirements xxxxxxxxxxxx treating xxx patients xxxxxxxx their xxxxxxx of xxxx and xxxxx them xxx well xxxxxx ReferencesACOG xxxxxx cancer xxxx assessment xxx screening xx average-risk xxxxx https xxx acog xxx clinical xxxxxxxxxxxxxxxxx practice-bulletin xxxxxxxx breast- xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx Ghoncheh x Pournamdar x amp xxxxxxxxxx H xxxxxxxxx and xxxxxxxxx and xxxxxxxxxxxx of xxxxxx cancer xx the xxxxx Asian xxxxxxx Journal xx Cancer xxxxxxxxxx sup xxxxx doi xxx apjcp x Kiviniemi x T xxx Hay x L xxxxxxxxx of xxx US xxxxxxxxxx Services xxxx Force xxxxxxxxxxx changes xx mammography xxxxxxxxx guidelines xxxxxxxx of xxxxxxxxx sources xx knowledge xxxxx recommendations xxx attitudes xxxxx updated xxxxxxxxx guidelines xx women xxxx and xxx Public xxxxxx https xxx org x - x Miller x An xxxxxxxxxx approach xx worker xxxxxxxxxxxxxxx and xxxxxx outcomes xxxxxxx conditions xxxxxxxxxxxxxx practice xxx Health xxxxxxxx AAOHN xxxxxxx https xxx org x - xxxxxxxxxxxxx Z xxx Salehiniya x lt x gt xxxxxxxxxxxxxxx characteristics xx and xxxx factors xxx breast xxxxxx in xxx world xx p xx Breast xxxxxx Targets xxx Therapy xxxxxx https xxx org xxxx s xxxxxxxxxx L xxxx L x amp xxxxxxx N x The xxxxxx of xxxxxx density xxxxxxxxxxxx laws xx supplemental xxxxxx imaging xxx breast xxxxxx Journal xx General xxxxxxxx Medicine xxxxx doi xxx s x - xMore Articles From Management
.ico)
.ico)
.ico)
.ico)
